These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

161 related items for PubMed ID: 8749033

  • 1. R(+)-8-OH-DPAT, a 5-HT1A receptor agonist, inhibits amphetamine-induced dopamine release in rat striatum and nucleus accumbens.
    Ichikawa J, Kuroki T, Kitchen MT, Meltzer HY.
    Eur J Pharmacol; 1995 Dec 12; 287(2):179-84. PubMed ID: 8749033
    [Abstract] [Full Text] [Related]

  • 2. The effect of serotonin(1A) receptor agonism on antipsychotic drug-induced dopamine release in rat striatum and nucleus accumbens.
    Ichikawa J, Meltzer HY.
    Brain Res; 2000 Mar 10; 858(2):252-63. PubMed ID: 10708676
    [Abstract] [Full Text] [Related]

  • 3. R(+)-8-OH-DPAT, a 5-HT1A receptor agonist, inhibits amphetamine-induced serotonin and dopamine release in rat medial prefrontal cortex.
    Kuroki T, Ichikawa J, Dai J, Meltzer HY.
    Brain Res; 1996 Dec 16; 743(1-2):357-61. PubMed ID: 9017269
    [Abstract] [Full Text] [Related]

  • 4. The 5-HT1A receptor antagonist (S)-UH-301 decreases dopamine release in the rat nucleus accumbens and striatum.
    Nomikos GG, Arborelius L, Höök BB, Hacksell U, Svensson TH.
    J Neural Transm (Vienna); 1996 Dec 16; 103(5):541-54. PubMed ID: 8811500
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. R(+)-8-OH-DPAT, a selective 5-HT(1A) receptor agonist, attenuated amphetamine-induced dopamine synthesis in rat striatum, but not nucleus accumbens or medial prefrontal cortex.
    Kuroki T, Dai J, Meltzer HY, Ichikawa J.
    Brain Res; 2000 Jul 28; 872(1-2):204-7. PubMed ID: 10924694
    [Abstract] [Full Text] [Related]

  • 7. Interactions between serotonin and dopamine in the control of impulsive choice in rats: therapeutic implications for impulse control disorders.
    Winstanley CA, Theobald DE, Dalley JW, Robbins TW.
    Neuropsychopharmacology; 2005 Apr 28; 30(4):669-82. PubMed ID: 15688093
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Prevention by (+/-)-8-hydroxy-2-(di-n-propylamino)tetralin of both catalepsy and the rises in rat striatal dopamine metabolism caused by haloperidol.
    Andersen HL, Kilpatrick IC.
    Br J Pharmacol; 1996 May 28; 118(2):421-7. PubMed ID: 8735647
    [Abstract] [Full Text] [Related]

  • 11. WAY-100635 inhibits 8-OH-DPAT-stimulated oxytocin, ACTH and corticosterone, but not prolactin secretion.
    Vicentic A, Li Q, Battaglia G, Van de Kar LD.
    Eur J Pharmacol; 1998 Apr 10; 346(2-3):261-6. PubMed ID: 9652368
    [Abstract] [Full Text] [Related]

  • 12. 8-OH-DPAT influences extracellular levels of serotonin and dopamine in the medial preoptic area of male rats.
    Lorrain DS, Matuszewich L, Hull EM.
    Brain Res; 1998 Apr 20; 790(1-2):217-23. PubMed ID: 9593901
    [Abstract] [Full Text] [Related]

  • 13. 8-OH-DPAT-induced release of hippocampal noradrenaline in vivo: evidence for a role of both 5-HT1A and dopamine D1 receptors.
    Hajós-Korcsok E, Sharp T.
    Eur J Pharmacol; 1996 Oct 31; 314(3):285-91. PubMed ID: 8957248
    [Abstract] [Full Text] [Related]

  • 14. Modulation of a (+)amphetamine discriminative stimulus in rats by 8-hydroxy-2-(N,N-di-n-propylamino)tetralin (8-OH DPAT).
    Young R, Bondareva T, Wesolowska A, Glennon RA.
    Pharmacol Biochem Behav; 2006 Apr 31; 83(4):612-7. PubMed ID: 16675002
    [Abstract] [Full Text] [Related]

  • 15. Differential serotoninergic and dopaminergic activities of the (R)- and the (S)-enantiomers of 2-(di-n-propylamino)tetralin.
    Yu H, Liu Y, Malmberg A, Mohell N, Hacksell U, Lewander T.
    Eur J Pharmacol; 1996 May 15; 303(3):151-62. PubMed ID: 8813561
    [Abstract] [Full Text] [Related]

  • 16. 5-Hydroxytryptamine(1A) receptor-stimulated [(35)S]GTPgammaS binding in rat brain: absence of regional differences in coupling efficiency.
    Meller E, Li H, Carr KD, Hiller JM.
    J Pharmacol Exp Ther; 2000 Feb 15; 292(2):684-91. PubMed ID: 10640306
    [Abstract] [Full Text] [Related]

  • 17. In vivo evidence for preferential role of dopamine D3 receptor in the presynaptic regulation of dopamine release but not synthesis.
    Gainetdinov RR, Sotnikova TD, Grekhova TV, Rayevsky KS.
    Eur J Pharmacol; 1996 Jul 25; 308(3):261-9. PubMed ID: 8858296
    [Abstract] [Full Text] [Related]

  • 18. Stimulation of serotonin (5-HT)1A receptors attenuates the locomotor, but not the discriminative, effects of amphetamine and cocaine in rats.
    Przegaliñski E, Filip M.
    Behav Pharmacol; 1997 Dec 25; 8(8):699-706. PubMed ID: 9832955
    [Abstract] [Full Text] [Related]

  • 19. Effects of 5-HT1A receptor stimulation on striatal and cortical M1 pERK induction by L-DOPA and a D1 receptor agonist in a rat model of Parkinson's disease.
    Lindenbach D, Dupre KB, Eskow Jaunarajs KL, Ostock CY, Goldenberg AA, Bishop C.
    Brain Res; 2013 Nov 06; 1537():327-39. PubMed ID: 24060645
    [Abstract] [Full Text] [Related]

  • 20. Activation of 5-HT1B receptors in the nucleus accumbens reduces amphetamine-induced enhancement of responding for conditioned reward.
    Fletcher PJ, Korth KM.
    Psychopharmacology (Berl); 1999 Feb 06; 142(2):165-74. PubMed ID: 10102769
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.